Plasma RNA quantification and HIV-1 divergent strains

Journal of Acquired Immune Deficiency Syndromes

Volumn 33, Issue 1, 2003, Pages 1-7

  Plantier, Jean Christophe ^a   Gueudin, Marie ^a   Damond, Florence ^b   Braun, Joséphine ^a   Mauclère, Philippe ^c   Simon, François ^a  

^a HÔPITAL CHARLES NICOLLE   (France)

^b BICHAT HOSPITAL   (France)

^c Centre Pasteur du Cameroun   (South Africa)

Author keywords

HIV 1 diversity; LCx; LightCycler; Viral load

Indexed keywords

VIRUS RNA;

ARTICLE; ASSAY; CONTROLLED STUDY; DIAGNOSTIC KIT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; VALIDATION PROCESS; VIRUS IDENTIFICATION; VIRUS LOAD; VIRUS STRAIN;

EID: 0038372693     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/00126334-200305010-00001     Document Type: Article

References (42)

1. de Baar MP, van Dooren MW, de Rooij E, et al. Single rapid real-time monitored isothermal RNA amplification assay for quantification of human immunodeficiency virus type 1 isolates from groups M, N, and O. J Clin Microbiol 2001;39:1378-1384.
2. Emery S, Bodrug S, Richardson BA, et al. Evaluation of performance of the Gen-Probe human immunodeficiency virus type 1 viral load assay using primary subtype A, C, and D isolates from Kenya. J Clin Microbiol 2000;38:2688-2695.
3. Robertson DL, Anderson JP, Bradac JA, et al. HIV-1 nomenclature proposal. Science 2000;288:55-56.
4. Charneau P, Borman AM, Quillent C, et al. Isolation and envelope sequence of a highly divergent HIV-1 isolate: definition of a new HIV-1 group. Virology 1994;205:247-253.
5. De Leys R, Vanderborght B, Vanden Haesevelde M, et al. Isolation and partial characterization of an unusual human immunodeficiency retrovirus from two persons of West-Central African origin. J Virol 1990;64:1207-1216.
6. Hampl H, Sawitzky D, Stoffler-Meilicke M, et al. First case of HIV-1 subtype 0 infection in Germany. Infection 1995;23:369-370.
7. Soriano V, Gutierrez M, Garcia-Lerma G, et al. First case of HIV-1 group O infection in Spain. Vox Sang 1996;71:66.
8. Gould K, Britvan L, Dryjanski J. HIV-1 group O infection in the USA. Lancet 1996;348:680-681.
9. Ayouba A, Souquieres S, Njinku B, et al. HIV-1 group N among HIV-1-seropositive individuals in Cameroon. Aids 2000;14:2623-2625.
10. Simon F, Mauclere P, Roques P, et al. Identification of a new human immunodeficiency virus type 1 distinct from group M and group O. Nat Med 1998;4:1032-1037.
11. Alaeus A, Lidman K, Sonnerborg A, et al. Subtype-specific problems with quantification of plasma HIV-1 RNA. Aids 1997;11: 859-865.
12. Coste J, Montes B, Reynes J, et al. Effect of HIV-1 genetic diversity on HIV-1 RNA quantification in plasma: comparative evaluation of three commercial assays. J Acquir Immune Defic Syndr Hum Retrovirol 1997;15:174-175.
13. Debyser Z, Van Wijngaerden E, Van Laethem K, et al. Failure to quantify viral load with two of the three commercial methods in a pregnant woman harboring an HIV type 1 subtype G strain. AIDS Res Hum Retroviruses 1998;14:453-459.
14. Gobbers E, Fransen K, Oosterlaken T, et al. Reactivity and amplification efficiency of the NASBA HIV-1 RNA amplification system with regard to different HIV-1 subtypes. J Virol Methods 1997;66:293-301.
15. Alaeus A, Leitner T, Lidman K, et al. Most HIV-1 genetic subtypes have entered Sweden. Aids 1997;11:199-202.
16. Couturier E, Damond F, Roques P, et al. HIV-1 diversity in France, 1996-1998. The AC 11 laboratory network. Aids 2000;14:289-296.
17. Holguin A, Aracil B, Alvarez A, et al. Prevalence of human immunodeficiency virus type 1 (HIV-1) non-B subtypes in foreigners living in Madrid, Spain, and comparison of the performances of the AMPLICOR HIV-1 MONITOR version 1.0 and the new automated version 1.5. J Clin Microbiol 2001;39:1850-1854.
18. Op de Coul EL, Coutinho RA, van der Schoot A, et al. The impact of immigration on env HIV-1 subtype distribution among heterosexuals in the Netherlands: influx of subtype B and non-B strains. Aids 2001;15:2277-2286.
19. Parry JV, Murphy G, Barlow KL, et al. National surveillance of HIV-1 subtypes for England and Wales: design, methods, and initial findings. J Acquir Immune Defic Syndr 2001;26:381-388.
20. Rayfield MA, Sullivan P, Bandea CI, et al. HIV-1 group O virus identified for the first time in the United States. Emerg Infect Dis 1996;2:209-212.
21. Simon F, Loussert-Ajaka I, Damond F, et al. HIV type 1 diversity in northern Paris, France. AIDS Res Hum Retroviruses 1996;12: 1427-1433.
22. Barin F, Courouce AM, Pillonel J, et al. Increasing diversity of HIV-1M serotypes in French blood donors over a 10-year period (1985-1995). Retrovirus Study Group of the French Society of Blood Transfusion. Aids 1997;11:1503-1508.
23. Boni J, Pyra H, Gebhardt M, et al. High frequency of non-B subtypes in newly diagnosed HIV-1 infections in Switzerland. J Acquir Immune Defic Syndr 1999;22:174-179.
24. Dietrich U, Ruppach H, Gehring S, et al. Large proportion of non-B HIV-1 subtypes and presence of zidovudine resistance mutations among German seroconvertors. Aids 1997;11:1532-1533.
25. Sonnerborg A, Durdevic S, Giesecke J, et al. Dynamics of the HIV-1 subtype distribution in the Swedish HIV-1 epidemic during the period 1980 to 1993. AIDS Res Hum Retroviruses 1997;13: 343-345.
26. Burgisser P, Vernazza P, Flepp M, et al. Performance of five different assays for the quantification of viral load in persons infected with various subtypes of HIV-1. Swiss HIV Cohort Study. J Acquir Immune Defic Syndr 2000;23:138-144.
27. Damond F, Apetrei C, Descamps D, et al. HIV-1 subtypes and plasma RNA quantification. Aids 1999;13:286-288.
28. Murphy DG, Cote L, Fauvel M, et al. Multicenter comparison of Roche COBAS AMPLICOR MONITOR version 1.5, Organon Teknika NucliSens QT with Extractor, and Bayer Quantiplex version 3.0 for quantification of human immunodeficiency virus type 1 RNA in plasma, J Clin Microbiol 2000;38:4034-4041.
29. Triques K, Coste J, Perret JL, et al. Efficiencies of four versions of the AMPLICOR HIV-1 MONITOR test for quantification of different subtypes of human immunodeficiency virus type 1. J Clin Microbiol 1999;37:110-116.
30. de Mendoza C, Alcami J, Sainz M, et al. Evaluation of the Abbott LCx quantitative assay for measurement of human immunodeficiency virus RNA in plasma. J Clin Microbiol 2002;40:1518-1521.
31. Swanson P, Soriano V, Devare SG, et al. Comparative performance of three viral load assays on human immunodeficiency virus type 1 (HIV-1) isolates representing group M (subtypes A to G) and group O: LCx HIV RNA quantitative, AMPLICOR HIV-1 MONITOR version 1.5, and Quantiplex HIV-1 RNA version 3.0. J Clin Microbiol 2001;39:862-870.
32. Swanson P, Harris BJ, Holzmayer V, et al. Quantification of HIV-1 group M (subtypes A-G) and group O by the LCx HIV RNA quantitative assay. J Virol Methods 2000;89:97-108.
33. Zanchetta N, Nardi G, Tocalli L, et al. Evaluation of the Abbott LCx HIV-1 RNA quantitative, a new assay for quantitative determination of human immunodeficiency virus type 1 RNA. J Clin Microbiol 2000;38:3882-3886.
34. Gueudin M, et al. In press.
35. Mauclere P, Loussert-Ajaka I, Damond F, et al. Serological and virological characterization of HIV-1 group O infection in Cameroon. Aids 1997;11:445-453.
36. Simon F, Souquiere S, Damond F, et al. Synthetic peptide strategy for the detection of and discrimination among highly divergent primate lentiviruses. AIDS Res Hum Retroviruses 2001;17:937-952.
37. Barin F, Lahbabi Y, Buzelay L, et al. Diversity of antibody binding to V3 peptides representing consensus sequences of HIV type 1 genotypes A to E: an approach for HIV type 1 serological subtyping. AIDS Res Hum Retroviruses 1996;12:1279-1289.
38. Plantier JC, Vergne L, Damond F, et al. Development and evaluation of a DNA enzyme immunoassay method for env genotyping of subtypes A through G of human immunodeficiency virus type 1 group M, with discrimination of the circulating recombinant forms CRF01_AE and CRF02_AG. J Clin Microbiol 2002;40:1010-1022.
39. Roques P, Robertson DL, Souquière S, et al. Phylogenetic analysis of 49 newly derived HIV-1 group O strains: high viral diversity but no group M-like subtype structure. Virology 2002 (in press).
40. Johanson J, Abravaya K, Caminiti W, et al. A new ultrasensitive assay for quantitation of HIV-1 RNA in plasma. J Virol Methods 2001;95:81-92.
41. Fleury H, Recordon-Pinson P, Caumont A, et al. HIV-1 diversity in France, 1999-2001: molecular characterization of non-B HIV-1 subtypes and potential impact on ARV susceptibility. AIDS Res Hum Retroviruses 2003 (in press).
42. Montavon C, Vergne L, Bourgeois A, et al. Identification of a new circulating recombinant form of HIV type 1, CRF11-cpx, involving subtypes A, G, J, and CRF01-AE, in Central Africa. AIDS Res Hum Retroviruses 2002;18:231-236.